Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 USD | +1.70% | -3.62% | -.--% |
05-14 | Kyverna Therapeutics Q1 Loss Narrows | MT |
05-14 | Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-.--% | 540M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- KYTX Stock
- News Kyverna Therapeutics, Inc.
- Kyverna Therapeutics Teams Up With Stanford University to Evaluate Investigational Multiple Sclerosis Drug